Shandong Weigao Group Medical Polymer Company Limited engages in the research and development, production, and sale of single-use medical devices in the People's Republic of China. It operates through Medical Device Products, Orthopaedic Products, Interventional Products, Pharma Packaging Products, Blood Management Products, and Others segments. The company offers vascular and non-vascular access infusion devices, infusion sets, syringes, puncture needles, and specialized single-use clinical collection kits; wound sutures, wound healing dressings, and wound cleaning and nonvascular catheter supporting extracorporeal devices; and blood collection, storage, separation, and sterilization equipment. It also provides prefilled syringes and pre-filled flush syringes; blood collection and blood glucose testing devices; and general anesthesia consumables, local anesthesia consumables, anesthesia auxiliary consumables, ICU equipment, and open and minimally invasive surgical equipment. In addition, the company engages in the production and sale of orthopedic devices; tumor and blood vessel interventional instruments; implantation materials and artificial organs; medical PVC granules, plastic packing bags, and carton boxes; industrial automatic equipment and parts; molds; hemodialysis equipment; and type I, type II, and type III medical devices. Further, it is involved in the finance leasing and factoring business; wholesale of type I medical devices, surgical devices, and other disposal medical products; provision of asset management, enterprise consulting, enterprise management advisory services, as well as logistics and storage services, as well as export its products. The company offers its products under the Jierui, Wego Ortho, Yahua, Bangde, and Hai Xing brands. It serves hospitals, blood stations, and other medical units; and distributors. The company was incorporated in 2000 and is based in Weihai, the People's Republic of China.
General Outlook
In simple terms, Shandong Weigao Group Medical Polymer Company Limited has 1130.582 M shares that people are buying and selling right now. When we look at how much money they make before expenses, they keep 0.522% as profit. This shows they're good at controlling costs and are financially stable. Their operating profit, which is money made from regular business activities, is 0.262%. This means they run their business efficiently. Lastly, after paying all their bills, they still have a profit of 0.200%. This tells us they're good at keeping money after all costs.
Return on Investments
The company's asset efficiency, represented by a robust 0.082% return, is a testament to Shandong Weigao Group Medical Polymer Company Limited's adeptness in optimizing resource deployment. Shandong Weigao Group Medical Polymer Company Limited's utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of 0.133%. Furthermore, the proficiency of Shandong Weigao Group Medical Polymer Company Limited in capital utilization is underscored by a remarkable 0.131% return on capital employed.
Stock Prices
Shandong Weigao Group Medical Polymer Company Limited's stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $3.62, while its low point bottomed out at $3.62. This variance in figures offers investors a lucid insight into the roller-coaster ride that is Shandong Weigao Group Medical Polymer Company Limited's stock market.
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”